These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19151586)

  • 1. Nanosize delivery as an emerging platform for cancer therapy.
    Li CQ; Zhang GX
    Cancer Biol Ther; 2008 Nov; 7(11):1860-2. PubMed ID: 19151586
    [No Abstract]   [Full Text] [Related]  

  • 2. Nanoparticles for cancer gene therapy: Recent advances, challenges, and strategies.
    Wang K; Kievit FM; Zhang M
    Pharmacol Res; 2016 Dec; 114():56-66. PubMed ID: 27771464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rigid nanoparticle-based delivery of anti-cancer siRNA: challenges and opportunities.
    Wang Z; Liu G; Zheng H; Chen X
    Biotechnol Adv; 2014; 32(4):831-43. PubMed ID: 24013011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selenium nanoparticles: potential in cancer gene and drug delivery.
    Maiyo F; Singh M
    Nanomedicine (Lond); 2017 May; 12(9):1075-1089. PubMed ID: 28440710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Encapsulation of nucleic acids and opportunities for cancer treatment.
    Brannon-Peppas L; Ghosn B; Roy K; Cornetta K
    Pharm Res; 2007 Apr; 24(4):618-27. PubMed ID: 17372693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Image-Guided Nanoparticle-Based siRNA Delivery for Cancer Therapy.
    Kim YD; Park TE; Singh B; Maharjan S; Cho KS; Park KP; Choi YJ; Arote RB; Cho CS
    Curr Pharm Des; 2015; 21(31):4637-56. PubMed ID: 26486148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Research progress in co-delivery of gene and chemotherapy drugs with nanocarriers for cancer therapy].
    Chen WG; Wang SB
    Yao Xue Xue Bao; 2013 Jul; 48(7):1091-8. PubMed ID: 24133974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atelocollagen-mediated siRNA delivery: future promise for therapeutic application.
    Fujimoto I; Takei Y
    Ther Deliv; 2014 Apr; 5(4):369-71. PubMed ID: 24856162
    [No Abstract]   [Full Text] [Related]  

  • 9. Targeted delivery of small interfering RNA: approaching effective cancer therapies.
    Pirollo KF; Chang EH
    Cancer Res; 2008 Mar; 68(5):1247-50. PubMed ID: 18316585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organic Nanoparticle-Based Combinatory Approaches for Gene Therapy.
    Singh BN; Prateeksha ; Gupta VK; Chen J; Atanasov AG
    Trends Biotechnol; 2017 Dec; 35(12):1121-1124. PubMed ID: 28818304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer therapy using oligonucleotide-based STAT3 inhibitors: will they deliver?
    Kortylewski M; Nechaev S
    Ther Deliv; 2014 Mar; 5(3):239-42. PubMed ID: 24592948
    [No Abstract]   [Full Text] [Related]  

  • 12. Nanotechnology for in vivo targeted siRNA delivery.
    Dahlman JE; Kauffman KJ; Langer R; Anderson DG
    Adv Genet; 2014; 88():37-69. PubMed ID: 25409603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Research advancement and prospects of nanotechnology in early diagnosis and treatment of cancer].
    Hu DH; Gong P; Ma YF; Cai LT
    Ai Zheng; 2009 Sep; 28(9):1000-3. PubMed ID: 19728922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomeres and telomerase. A survey about methods and recent advances in cancer diagnostic and therapy.
    Weise JM; Günes C
    Histol Histopathol; 2006 Nov; 21(11):1249-61. PubMed ID: 16874667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging nanotechnology approaches for HIV/AIDS treatment and prevention.
    Mamo T; Moseman EA; Kolishetti N; Salvador-Morales C; Shi J; Kuritzkes DR; Langer R; von Andrian U; Farokhzad OC
    Nanomedicine (Lond); 2010 Feb; 5(2):269-85. PubMed ID: 20148638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of a Nano DDS for Cancer Immunotherapy Based on Llipid Nanoparticles].
    Nakamura T
    Yakugaku Zasshi; 2018; 138(12):1443-1449. PubMed ID: 30504656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanodelivery systems for nucleic acid therapeutics in drug resistant tumors.
    Iyer AK; Duan Z; Amiji MM
    Mol Pharm; 2014 Aug; 11(8):2511-26. PubMed ID: 24661041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoscale delivery systems for microRNAs in cancer therapy.
    Boca S; Gulei D; Zimta AA; Onaciu A; Magdo L; Tigu AB; Ionescu C; Irimie A; Buiga R; Berindan-Neagoe I
    Cell Mol Life Sci; 2020 Mar; 77(6):1059-1086. PubMed ID: 31637450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioreducible polymer-delivered siRNA targeting human telomerase reverse transcriptase for human cancer gene therapy.
    Xia W; Lin C
    Ther Deliv; 2012 Apr; 3(4):439-42. PubMed ID: 22834075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PEGylated carboxymethyl chitosan/calcium phosphate hybrid anionic nanoparticles mediated hTERT siRNA delivery for anticancer therapy.
    Xie Y; Qiao H; Su Z; Chen M; Ping Q; Sun M
    Biomaterials; 2014 Sep; 35(27):7978-91. PubMed ID: 24939077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.